Chasing Immune Checkpoint Inhibitors in Ovarian Cancer: Novel Combinations and Biomarker Discovery

A deep understanding of the tumor microenvironment and the recognition of tumor-infiltrating lymphocytes as a prognostic factor have resulted in major milestones in immunotherapy that have led to therapeutic advances in treating many cancers. Yet, the translation of this knowledge to clinical succes...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2023-06, Vol.15 (12), p.3220
Hauptverfasser:	Colombo, Ilaria, Karakasis, Katherine, Suku, Sneha, Oza, Amit M
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis inhibitors Biomarkers Cancer Cancer therapies Chemotherapy Clinical trials Cytotoxicity Genotype & phenotype Health aspects Immune checkpoint inhibitors Immune system Immunotherapy Ipilimumab Lymphocytes Medical prognosis Monosaccharides Ovarian cancer Patients Poly(ADP-ribose) polymerase Review Sugars Tumor microenvironment Tumor-infiltrating lymphocytes Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!